Francesco Tarantini

719 total citations
36 papers, 450 citations indexed

About

Francesco Tarantini is a scholar working on Hematology, Genetics and Physiology. According to data from OpenAlex, Francesco Tarantini has authored 36 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 12 papers in Genetics and 9 papers in Physiology. Recurrent topics in Francesco Tarantini's work include Acute Myeloid Leukemia Research (14 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Allergic Rhinitis and Sensitization (7 papers). Francesco Tarantini is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Allergic Rhinitis and Sensitization (7 papers). Francesco Tarantini collaborates with scholars based in Italy, France and Germany. Francesco Tarantini's co-authors include Giorgio Walter Canonica, Fulvio Braido, Giovanni Passalacqua, Martín Penagos, Enrico Compalati, Ilaria Baiardini, Carlos E. Baena‐Cagnani, Giorgina Specchia, Antonella Zagaria and Francesco Albano and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Francesco Tarantini

33 papers receiving 433 citations

Peers

Francesco Tarantini
Angela Duff Hogan United States
P Macchia Italy
Laura Rapley United Kingdom
Matthew Parsons United States
Francesco Tarantini
Citations per year, relative to Francesco Tarantini Francesco Tarantini (= 1×) peers A. Prudhomme

Countries citing papers authored by Francesco Tarantini

Since Specialization
Citations

This map shows the geographic impact of Francesco Tarantini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Tarantini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Tarantini more than expected).

Fields of papers citing papers by Francesco Tarantini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Tarantini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Tarantini. The network helps show where Francesco Tarantini may publish in the future.

Co-authorship network of co-authors of Francesco Tarantini

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Tarantini. A scholar is included among the top collaborators of Francesco Tarantini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Tarantini. Francesco Tarantini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tarantini, Francesco, Cosimo Cumbo, Luisa Anelli, et al.. (2024). Venetoclax-based treatment in acute myeloid leukemia: an unexpected bonus on the path to allogeneic hematopoietic stem cell transplant?. Leukemia & lymphoma. 65(12). 1777–1788.
2.
Anelli, Luisa, Antonella Zagaria, Francesco Tarantini, et al.. (2023). IKAROS in Acute Leukemia: A Positive Influencer or a Mean Hater?. International Journal of Molecular Sciences. 24(4). 3282–3282. 7 indexed citations
3.
Coccaro, Nicoletta, Antonella Zagaria, Luisa Anelli, et al.. (2023). Optical Genome Mapping as a Tool to Unveil New Molecular Findings in Hematological Patients with Complex Chromosomal Rearrangements. Genes. 14(12). 2180–2180. 2 indexed citations
4.
Pozzi, Paolo, Roberto Boffi, Chiara Veronese, et al.. (2023). Cytisine as a smoking cessation aid: Preliminary observations with a modified therapeutic scheme in real life. Tumori Journal. 110(2). 124–131. 3 indexed citations
5.
Tarantini, Francesco, Cosimo Cumbo, Antonella Zagaria, et al.. (2023). Clonal hematopoiesis onset in chronic myeloid leukemia patients developing an adverse cardiovascular event. Leukemia Research. 127. 107023–107023. 1 indexed citations
6.
Coccaro, Nicoletta, Luisa Anelli, Antonella Zagaria, et al.. (2023). Feasibility of Optical Genome Mapping in Cytogenetic Diagnostics of Hematological Neoplasms: A New Way to Look at DNA. Diagnostics. 13(11). 1841–1841. 16 indexed citations
7.
Cumbo, Cosimo, Paola Orsini, Francesco Tarantini, et al.. (2023). TNFRSF13B gene mutation in familial acute myeloid leukemia: A new piece in the complex scenario of hereditary predisposition?. Hematological Oncology. 41(5). 942–946. 2 indexed citations
8.
Cumbo, Cosimo, Luisa Anelli, Antonella Zagaria, et al.. (2023). The Role of NLRP3, a Star of Excellence in Myeloproliferative Neoplasms. International Journal of Molecular Sciences. 24(5). 4860–4860. 2 indexed citations
9.
Cumbo, Cosimo, Francesco Tarantini, Antonella Zagaria, et al.. (2022). Clonal Hematopoiesis at the Crossroads of Inflammatory Bowel Diseases and Hematological Malignancies: A Biological Link?. Frontiers in Oncology. 12. 873896–873896. 13 indexed citations
10.
Tarantini, Francesco, Cosimo Cumbo, Luisa Anelli, et al.. (2022). Exploring the Potential of Eltrombopag: Room for More?. Frontiers in Pharmacology. 13. 906036–906036. 10 indexed citations
11.
Cumbo, Cosimo, Francesco Tarantini, Luisa Anelli, et al.. (2022). FLT3 mutational analysis in acute myeloid leukemia: Advantages and pitfalls with different approaches. Blood Reviews. 54. 100928–100928. 6 indexed citations
12.
Tarantini, Francesco, Cosimo Cumbo, Luisa Anelli, et al.. (2022). IRF4 Gene Expression on the Trail of Molecular Response: Looking at Chronic Myeloid Leukemia from Another Perspective. Acta Haematologica. 146(1). 39–45. 1 indexed citations
13.
Sgherza, Nicola, Francesco Tarantini, Luigi Vimercati, et al.. (2022). Prospective, case-control study of serological response after two doses of BNT162b2 anti-SARS-CoV-2 mRNA vaccine in transfusion-dependent thalassemic patients. Mediterranean Journal of Hematology and Infectious Diseases. 14(1). e2022056–e2022056.
14.
Minervini, Crescenzio Francesco, Cosimo Cumbo, Paola Orsini, et al.. (2021). Nanopore sequencing approach for immunoglobulin gene analysis in chronic lymphocytic leukemia. Scientific Reports. 11(1). 17668–17668. 5 indexed citations
15.
Tarantini, Francesco, Cosimo Cumbo, Luisa Anelli, et al.. (2021). Inside the biology of early T-cell precursor acute lymphoblastic leukemia: the perfect trick. Biomarker Research. 9(1). 89–89. 5 indexed citations
16.
Tarantini, Francesco, Luisa Anelli, Giuseppe Ingravallo, et al.. (2019). <p>Skin lesions in chronic myeloid leukemia patients during dasatinib treatment</p>. Cancer Management and Research. Volume 11. 7991–7996. 8 indexed citations
17.
Baiardini, I., Fulvio Braido, Francesco Tarantini, et al.. (2008). ARIA‐suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN Review. Allergy. 63(6). 660–669. 46 indexed citations
18.
Braido, Fulvio, et al.. (2007). Bacterial lysate in the prevention of acute exacerbation of COPD and in respiratory recurrent infections.. PubMed. 2(3). 335–45. 32 indexed citations
19.
Tarantini, Francesco, Ilaria Baiardini, Giovanni Passalacqua, Fulvio Braido, & Giorgio Walter Canonica. (2007). Asthma treatment: ‘magic bullets which seek their own targets’. Allergy. 62(6). 605–610. 27 indexed citations
20.
Baiardini, Ilaria, Fulvio Braido, Omar Fassio, et al.. (2005). A new tool to assess and monitor the burden of chronic cough on quality of life: Chronic Cough Impact Questionnaire. Allergy. 60(4). 482–488. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026